s6y

Curanex Pharmaceuticals Inc

Ticker
CURX
CIK
2025942
Industry
Pharmaceutical Preparations

Financials 7

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025

News 13

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 13 news filings

Ownership 9

  1. 3 Initial statement of beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities

Prospectus 19

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  4. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  5. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  6. S-1/A General form of registration statement for all companies including face-amount certificate companies
  7. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  10. S-1/A General form of registration statement for all companies including face-amount certificate companies

All 19 prospectus filings

Proxies 2

  1. DEF 14C Definitive information statements
  2. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

Other 16

  1. 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
  2. CERT Certification by an exchange approving securities for listing
  3. EFFECT Notice of Effectiveness
  4. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. UPLOAD Letter (PDF)

All 16 other filings